FDA Adverse Event Injury Summary report: N

AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM POSTERIOR

MDR report key: 2971840 · Received February 19, 2013

Report

Report Number
1018233-2013-00445
Event Type
Injury
Date Received
February 19, 2013
Report Date
June 20, 2016
Manufacturer
C.R. BARD, INC.
Product Code
FTL
PMA / PMN Number
K082571
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY
Health Professional
N

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE FINISHED PRODUCT MET ALL SPECIFICATIONS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE EVENTS: ¿POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE.¿ (B)(4).

Description of Event or Problem · 1

THE PATIENT¿S ATTORNEY ALLEGED A DEFICIENCY AGAINST THE DEVICE. ADD¿L INFO HAS BEEN REQUESTED, BUT NOT YET RECEIVED. ASSOCIATED MDR: 1018233-2013-00445 AND 1018233-2013-00447.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
72862 AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM POSTERIOR Mesh, surgical, polymeric FTL C.R. BARD, INC. NA CVSKX008

Patients

Seq Age Sex Outcome Treatment
1 45 YR Female Required Intervention ALIGN TO URETHRAL SUPPORT SYSTEM| AVAULTA PLUS ANTERIOR BIOSYNTHETIC SUPPORT SYSTEM| OBTRYX TRANSOBTURATOR MID-URETHRAL SLING SYSTEM| OBTRYX TRANSOBTURATOR MID-URETHRAL SLING SYSTEM| ALIGN TO URETHRAL SUPPORT SYSTEM| AVAULTA PLUS ANTERIOR BIOSYNTHETIC SUPPORT SYSTEM